GRAL — GRAIL, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1699031 ·
Last close
$105.88
Market Cap
$4.76B
52W High
$166.48
52W Low
$41.50
ADV30
884,064
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 44,687,000 | -12,566,000 | -148,360,000 | -110,247,000 | 2,843,686,000 | 55,645,000 | 301,032,000 |
| Mar 2026 | 40,785,000 | -14,307,000 | -135,765,000 | -93,187,000 | 2,803,474,000 | 69,344,000 | 302,788,000 |
| Dec 2025 | 43,597,000 | -11,136,000 | -124,411,000 | -99,176,000 | 2,922,015,000 | 249,727,000 | 344,153,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-294,749,000
Investing CF
$-310,043,000
Financing CF
$423,321,000
CapEx
$-1,413,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-9.50
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,415,115,000
Inventory
$17,763,000
Receivables
$19,757,000
ST Investments
$805,964,000
EBIT TTM
$-533,827,000
Pretax Income TTM
$-529,467,000
Interest Exp TTM
—
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$166,604,000
EBITDA
$-398,216,992
Free Cash Flow
$-103,579,128
Enterprise Value
$4,731,998,208
Total Cash
$788,675,968
Total Debt
$85,848,000
Shares Out
44,962,171
Trailing EPS
$-9.22
Book Value
$54.82
ROE
-17.3%
ROA
-13.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 147,172,000 | -534,163,000 | -408,351,000 | 2,922,015,000 | 344,153,000 | 2,577,862,000 | -299,007,000 |
| Dec 2024 | 125,595,000 | -768,222,000 | -2,027,005,000 | 2,983,307,000 | 479,902,000 | 2,503,405,000 | -577,156,000 |
| Dec 2023 | 93,105,000 | -796,916,000 | -1,465,685,000 | 3,913,814,000 | 267,627,000 | 0 | -595,800,000 |
| Dec 2022 | 55,550,000 | -742,459,000 | -5,399,098,000 | 4,937,986,000 | 291,825,000 | 0 | -561,313,000 |
TTM Snapshot
Revenues TTM
$165,263,000
NetIncome TTM
$-391,587,000
OpCashFlow TTM
—
Assets (Latest)
$2,843,686,000
Forward EPS
$-8.25
Max Pain — expiry 2027-01-15
max pain strike: $85.00 · spot: $102.10 · call oi: 4,878 · put oi: 2,488
Expected Move to 2027-01-15:
±$26.70
(26.15%) —
implied range
$75.40 –
$128.80
· ATM straddle on $100.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OPCH | Option Care Health, Inc. | $4.74B | $31.63 | — |
| SHC | Sotera Health Co | $4.58B | $16.05 | — |
| CON | Concentra Group Holdings Parent, Inc. | $5.36B | $42.38 | — |
| BLLN | BillionToOne, Inc. | $4.22B | $97.50 | — |
| LFST | LifeStance Health Group, Inc. | $5.39B | $14.17 | — |
News headlines (Yahoo Finance, 1h cache)
GRAIL Inc (GRAL) (Q3 2026) Earnings Call Highlights: FDA Nod on the Horizon as Galleri Gains ...
2026-11-10 01:05 · Yahoo
Is GRAIL (GRAL) Fully Valued As Fresh Earnings Reignite Questions Over Galleri?
2026-11-05 16:16 · Yahoo
GRAIL (GRAL) Q3 2026 Earnings Call Transcript
2026-11-05 15:58 · Yahoo
GRAIL Q3 Earnings Call Ties FDA Review to Pricing and Sales Growth
2026-11-05 14:00 · Yahoo
GRAIL, Inc. Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
What GRAIL (GRAL) Said on Its Q3 Earnings Call
2026-11-05 01:14 · Yahoo
Grail tumbles as revenue misses estimates despite FDA vote
2026-11-04 22:13 · Yahoo
GRAIL Reports Third Quarter 2026 Financial Results
2026-11-04 21:02 · Yahoo
GRAIL, Inc. (GRAL) Surged After FDA Panel Backed Its Cancer Detection Test: Here’s Why
2026-11-03 18:44 · Yahoo
How Long Can GRAIL Keep Burning Cash?
2026-11-03 11:56 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.